CAPILLARYS™ 2 Flex Piercing – Flexibility for all laboratories
Coming from a leading position in protein electrophoresis, SEBIA has more recently diversified its activity in the field of haemoglobinopathies diagnosis, to fulfill the growing worldwide demand for national screening programs. Introducing today two new technologies for newborn screening and adult testing, SEBIA offers the broadest choice of multipurpose systems and methods, CAPILLARYS™ 2 Neonat Fast (dry spot, cord blood, packed red cells) and CAPILLARYS™ 2 Flex Piercing (Whole blood-capped tubes hemoglobin, serum, urine).
SEBIA has unveiled the latest addition to its automated capillary electrophoresis portofolio, the innovative CAPILLARYS™ 2 Flex Piercing for clinical diagnostic laboratories. Based on the proven technology of the original CAPILLARYS™ instrument, the new system offers additional flexibility for all laboratories and features cap piercing capabilities for hemoglobin whole blood.
B. ADELUS, CEO of SEBIA , commented: “We are very pleased with the improved capabilities of CAPILLARYS™ 2 Flex Piercing. Our R&D experts have developed a system that gives a flexible choice to the laboratories. They can use it for its versatility or dedicate it for haemoglobinopathy testing.”
As a multipurpose instrument, CAPILLARYS™ 2 Flex Piercing offers a comprehensive menu including haemoglobins, proteins electrophoresis, immunotyping and CDT (carbohydrate deficient transferin).
For haemoglobinopathy testing, the new cap piercing capability streamlines workflow, offering a high throughput of up to 37 Hb samples / hour, and maximizes biohazard safety. Once primary sample tubes are loaded onto the system, the sample rack is gently inverted to ensure whole blood samples remain homogeneous and produce accurate results. Positive sample identification ensures full traceability from primary sample tube to final result.
These latest innovations strengthen SEBIA’s leadership in the field of electrophoresis technology, and position the company as a key player in haemoglobinopathies diagnosis.